CT-guided radioactive 125I seed implantation for the treatment of mediastinal metastases: initial results in 11 patients
10.3969/j.issn.1008-794X.2017.07.013
- VernacularTitle:CT引导放射性125I粒子植入治疗纵隔转移瘤11例
- Author:
Xianhai ZHU
;
Weiyu WANG
;
Hanlin QING
;
Changgao SHI
;
Jun XU
;
Tao XIA
;
Lei ZHOU
- Keywords:
mediastinal lymph node metastasis;
125I seed implantation;
interstitial brachytherapy
- From:
Journal of Interventional Radiology
2017;26(7):632-635
- CountryChina
- Language:Chinese
-
Abstract:
Objective To discuss the technical method,safety and clinical efficacy of CT-guided 125I radioactive seed implantation for the treatment of mediastinal lymph node metastases.Methods CT-guided 125I radioactive seed implantation was carried out in 11 patients with mediastinal lymph node metastases.Before 125I seed implantation,the interstitial brachytherapy treatment planning system (TPS) was employed to formulate a treatment plan.The particles with radioactivity of (1.11-2.96) × 107Bq (0.3-0.8 mCi) were used for the implantation.Postoperative complications were recorded.The local lesion control rate and the effective rate of pain relief were evaluated at one,3,6 and 12 months after 125I seed implantation.Results After 125I seed implantation,pneumothorax occurred in 3 patients,tracheal fistula in one patient,and pulmonary infection in one patient.The local lesion control rates at one,3,6 and 12 months were 81.8％,90.9％,72.7％ and 72.7％ respectively;the effective rate of pain relief at one week,one,3,6 and 12 months were 100％,90.9％,90.9％,81.8％ and 72.7％ respectively.Conclusion For the treatment of mediastinal lymph node metastases,CT-guided radioactive 125I seed implantation is less-invasive with less complications,and it carries reliable local lesion control rate.Therefore,this technique is a safe therapeutic means.
